Thrombopoietin Completed Phase 3 Trials for Thrombocytopenia / Hematologic Disease and Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02487563Prospective Study of Patients With Thrombocytopenia Following HSCT